Photoacoustic flow cytometry could allow early thrombosis detection

Sept. 22, 2016
Researchers conducted a series of experiments on mice to detect thrombosis using photoacoustic flow cytometry.

The Department of Biological and Medical Physics at the Moscow Institute of Physics and Technology (MIPT; Russia) led a team of researchers from the University of Arkansas for Medical Science (UAMS; Little Rock, AR), University Hospital Frankfurt, and University Hospital Dresden (both in Germany) on a series of experiments on mice to detect thrombosis (blood clotting) using photoacoustic flow cytometry.

Related: The wide-ranging benefit of photoacoustic commercialization

A thrombus formation is a healthy response to injury intended to prevent bleeding, but can be harmful in case of thrombosis, when clots obstruct blood flow through blood vessels. A thrombus lodging inside a blood vessel is called an embolus (an embolus may be a fat globule, a bubble of air, or another gas). Thromboembolism is the flow of a clot that breaks loose in the bloodstream to block another vessel. It is a significant cause of morbidity and mortality, especially in adults.

Healthy vein, thrombus formation, and its detaching from a vessel wall, leading to thromboembolism.

Existing methods do not provide accurate results and are not able to destroy thrombi. Doppler ultrasound techniques have shown promise for detecting a large thrombus in vivo, but this method cannot detect micro-thrombi, suffers from artifacts, and requires highly trained personnel. As a result, many thromboses remain undetectable: about 5–10% of patients die because of a failure to diagnose rather than inadequate therapy. Although the risk of recurrence decreases with longer durations of preventive anticoagulant treatment, there is no tool for estimating the risk of thrombus-related complications vs. the risk of bleeding-associated complications—particularly hemorrhage.

So, the research team used photoacoustic flow cytometry as a theranostics (a combination of diagnostics and therapy) approach. The method, which involves irradiating fluorescent dye-labeled cells with a laser beam, provides high spatial resolution for detecting signals up to a few millimeters and potentially destroying the blood clots. The specific wavelength excites fluorescent markers and they emit light at their own wavelength (which differs from the excitation wavelength). The emitted light is collected by a lens and mirror system and decomposed. The detected light is then converted into electrical impulses recognized by a computer, which analyzes the data and plots graphs. Peaks on the graph indicate the blood clot and its type. During the experiment, the mice were injected with a fluorescent dye and the laser was directed onto the blood vessels in their paws.

In the photoacoustic flow cytometry method, the specific wavelength excites fluorescent markers in cells and they emit light at their own wavelength (which differs from the excitation wavelength). The emitted light is collected by a lens and mirror system and converted into electrical impulses recognized by a computer, which analyzes the data and plots graphs.

In this preclinical study, the scientists conducted experiments on two groups of mice: healthy and melanoma-bearing. In the group of healthy mice, either clamps were applied to their legs or an incision was made by cutting through the skin and muscle on the mouse's back. In both situations, emboli were produced. In the melanoma-bearing mouse model, researchers observed a correlation between the presence of white emboli and melanoma.

The signals obtained were first averaged 10 times to increase the signal-to-noise ratio, followed by tracing the peak-to-peak amplitude of waveforms. The appearance of a negative peak indicates the passage of a low absorbing object (e.g., white embolus). Traces were then analyzed for the presence of positive and negative peaks exceeding the thresholds obtained from a control experiment.

The method, says Alexander Melerzanov, Ph.D., dean of MIPT, could also be used to destroy blood clots, which is something that the research team is planning to work on in following experiments. The team, he says, expects that a clinical device using the method could be attached to a patient's hand, or bypass tubes in the operating room or during a transfusion procedure.

Full details of the work appear in the journal PLOS One; for more information, please visit

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Request a quote: Micro 3D Printed Part or microArch micro-precision 3D printers

April 11, 2024
See the results for yourself! We'll print a benchmark part so that you can assess our quality. Just send us your file and we'll get to work.

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Precision Motion Control for Sample Manipulation in Ultra-High Resolution Tomography

April 10, 2024
Learn the critical items that designers and engineers must consider when attempting to achieve reliable ultra-high resolution tomography results here!

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!